Prof. Andres Metspalu
University of Tartu, Estonia
Dr. Jaanus Pikani
Estonian Genome Foundation, Estonia
|
 |
Speakers (as of September 5th, 2001)
-
Prof. Stylianos E. Antonarakis, Department
of Medical Genetics, University of Geneva, Switzerland
-
Prof. Ralf Baumeister, Genzentrum,
Ludwig-Maximilians-Universität, München, Germany
-
Dr. Andreas Braun, Chief Medical Officer, Sequenom
Inc., USA
-
Dr. Mark S. Chee, Vice President of Genomics, Illumina
Inc., USA
-
Dr. Francois Cambien, Institut National
de la Sante et de la Recherche Medicale (INSERM), Paris, France
-
Dr. Massimo Carella, Telethon Institute of Genetics and Medicine
(TIGEM), Napoli, Italy
-
Dr. Roger B Derbyshire, associate director, Orchid
BioSciences Europe Ltd, UK
-
Dr. Ian Dunham, Sanger Centre,
UK
-
Stanford (Ford) N. Goldman, Jr., Mintz,
Levin, Cohn, Ferris, Glovsky and Popeo, P.C., USA
-
Prof. Richard Grosse, CEO, InGene,
Germany
-
Dr. Olli-P. Kallioniemi, National
Human Genome Research Institute, National Institutes of Health, Bethesda,
USA
-
Dr. Kalev Kask, Stanford University,
USA
-
Dr. Priit Kogerman, National Institute
of Chemical Physics and Biophysics, Tallinn, Estonia
-
Prof. Charles Kurland, University
of Lund, Sweden
-
Prof. Cheng Chi Lee, Baylor
College of Medicine, Houston, USA
-
Prof. Klaus Lindpaintner, VP and Director, Roche
Genetics,
F.
Hoffmann-La Roche AG, Switzerland
-
Dr. Wojciech Makalowski, National
Center for Biotechnology Information (NIH), Bethesda, USA
-
Prof. Thomas Meitinger, Institute of Human Genetics, Neuherberg,
Germany
-
Prof. Andres Metspalu, Department
of Biotechnology, University of Tartu,
Estonia
-
Prof. Gisli Palsson, Director and Professor, Institute of Anthropology,
University
of Iceland, Iceland
-
Prof. Giovanni Romeo, Unit of Genetic Susceptibility to Cancer,
International
Agency for Research on Cancer, Lyon, France
-
Dr. Nick Short, CEO, UVS
Iceland Genomics Corporation, Iceland
-
Prof. Erwin Schurr, McGill University,
Montreal, Canada
-
Prof. Mart Ustav, Department
of Microbiology and Virology, University
of Tartu, Estonia
-
Dr. David G. Wang, Executive Vice President, First
Genetic Trust Inc., USA
|
